NAD+ 1g & Retatrutide : A UK Update
The emerging interest in NAD+ supplementation, particularly at a significant dosage of 1g , continues to rise within the British medical community. At the same time , attention is directed toward Retatrutide, a groundbreaking GLP-1 analogue being viewed by many as a potential advancement to Tirze